United States

Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

27 Feb 2017
Change (% chg)

$0.25 (+18.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Mon, Feb 27 2017

BRIEF-Novavax reports Q4 loss per share $0.21

* Novavax reports fourth quarter and year-end 2016 financial results

BRIEF-Novavax reports Q3 loss per share $0.24

* Q3 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S

Novavax cuts jobs to push ahead with respiratory vaccine for elderly

Nov 9 Novavax Inc said on Wednesday it would cut 30 percent of its global workforce, or 164 jobs, to help fund the testing of its vaccine for a common respiratory virus in the elderly, about two months after failing a late-stage study.

Novavax vaccine for respiratory disease fails in late stage trial

Novavax Inc said on Thursday that its experimental vaccine for a serious infectious respiratory disease failed at the final stage of human testing, sending its stock plunging more than 80 percent.

Select another date:

More From Around the Web